Zoekresultaten

From 11 to 19 March, The European Fine Art Fair (TEFAF) will take place in Maastricht. Some 270 galleries from more than 20 countries will present prestigious works of art.

Estate investors financially benefit from sustainable buildings, says associate professor of the Maastricht University School of Business and Economics. His research into the financial effects of sustainable construction is discussed in an article in the Huffington Post.

In this workshop, you learn how to approach a case interview and how to train for it. At the end you have practised part of a case interview and gained valuable tips and tricks on how to perform well. 

Ir. Fianne Sips (Dept. of Biomedical Engineering, Eindhoven University of Technology, Netherlands) will present a lecture: 'In silico investigation of individual bile acid dynamics and Roux-en-Y Gastric Bypass-induced elevation of bile acid concentrations' for the MaCSBio Lecture Series

The Department of Health, Ethics and Society at the Faculty of Health, Medicine and Life Sciences organses the visit of six senior scientists from the China National Environmental Monitoring Centre (CNEMC) to Maastricht University.

The board of the Faculty of Health, Medicine and Life Sciences of Maastricht University has appointed Professor Maurice Zeegers as the new scientific director of CAPHRI, the School for Public Health and Primary Care of Maastricht University.

Rok Hrzic won the Education Prize for Best Tutor and Matt Commers won the Honors Award of Education on November 20, 2019. These prizes were issued in the domain of the Faculty of Health Medicine and Life Sciences.

The VIVA400 is a list of 400 inspiring women who shine in their field of expertise and who are nominated because of their talents. Our Alie de Boer is on that list in the category ‘Knappe koppen’ (brainiacs).

This program teaches advanced research skills in economics and finance, with an optional specialisation in econometrics and operations research. Work with top researchers and prepare for a PhD or research roles in academia, business, or government.

Dr. Robert Mays, Vice President of Regenerative Medicine and Head of Neuroscience at Athersys Inc. Title: ‘Conserved Mechanisms Underlying the Benefit of MultiStem Cell Therapy, for Treatment of Acute Injuries of the Central Nervous System’